Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A TEICHER

Showing results (61-70 of 372) with videos related to

Pageof 38
Sort By:
Cancer Letters|October 14, 1994
SR-4233 (Tirapazamine) acts as an uncoupler of oxidative phosphorylation in human MCF-7 breast carcinoma cellsG Ara, C N Coleman, B A Teicher
British Medical Journal (Clinical Research Ed.)|June 6, 1981
Labetalol-induced toxic myopathyA Teicher, T Rosenthal, E Kissin, et al.
Cancer Chemotherapy and Pharmacology|April 29, 1998
Paclitaxel/carboplatin administration along with antiangiogenic therapy in non-small-cell lung and breast carcinoma modelsR S Herbst, H Takeuchi, B A Teicher
Cancer Chemotherapy and Pharmacology|January 1, 1996
Postlabeling detection of DNA adducts of antitumor alkylating agentsG H Zhou, B A Teicher, E Frei
International Journal of Cancer|November 15, 1985
Differential enhancement of melphalan cytotoxicity in tumor and normal tissue by Fluosol-DA and oxygen breathingB A Teicher, S A Holden, C M Rose
Journal of the National Cancer Institute|December 1, 1985
Effect of oxygen on the cytotoxicity and antitumor activity of etoposideB A Teicher, S A Holden, C M Rose
International Journal of Radiation Oncology, Biology, Physics|May 1, 1991
Effect of environmental conditions (pH, oxygenation, and temperature) on misonidazole cytotoxicity and radiosensitization in vitro and in vivo in FSaIIC fibrosarcomaS A Holden, B A Teicher, T S Herman
Radiation Research|October 1, 1989
DNA interaction, cytotoxicity, and radiosensitization with PtCl4(Nile Blue)2 and PtCl4(Neutral Red)2B A Teicher, T S Herman, M E Kaufmann
Cancer Research|November 15, 1988
Combined modality therapy with bleomycin, hyperthermia, and radiationB A Teicher, T S Herman, S A Holden
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Combination of antiangiogenic therapy with other anticancer therapies: results, challenges, and open questionsGiampietro Gasparini, Raffaele Longo, Massimo Fanelli, et al.
Pageof 38

Showing results (61-70 of 372) with videos related to

Sort By:
Pageof 38
Cancer Letters|October 14, 1994
SR-4233 (Tirapazamine) acts as an uncoupler of oxidative phosphorylation in human MCF-7 breast carcinoma cellsG Ara, C N Coleman, B A Teicher
British Medical Journal (Clinical Research Ed.)|June 6, 1981
Labetalol-induced toxic myopathyA Teicher, T Rosenthal, E Kissin, et al.
Cancer Chemotherapy and Pharmacology|April 29, 1998
Paclitaxel/carboplatin administration along with antiangiogenic therapy in non-small-cell lung and breast carcinoma modelsR S Herbst, H Takeuchi, B A Teicher
Cancer Chemotherapy and Pharmacology|January 1, 1996
Postlabeling detection of DNA adducts of antitumor alkylating agentsG H Zhou, B A Teicher, E Frei
International Journal of Cancer|November 15, 1985
Differential enhancement of melphalan cytotoxicity in tumor and normal tissue by Fluosol-DA and oxygen breathingB A Teicher, S A Holden, C M Rose
Journal of the National Cancer Institute|December 1, 1985
Effect of oxygen on the cytotoxicity and antitumor activity of etoposideB A Teicher, S A Holden, C M Rose
International Journal of Radiation Oncology, Biology, Physics|May 1, 1991
Effect of environmental conditions (pH, oxygenation, and temperature) on misonidazole cytotoxicity and radiosensitization in vitro and in vivo in FSaIIC fibrosarcomaS A Holden, B A Teicher, T S Herman
Radiation Research|October 1, 1989
DNA interaction, cytotoxicity, and radiosensitization with PtCl4(Nile Blue)2 and PtCl4(Neutral Red)2B A Teicher, T S Herman, M E Kaufmann
Cancer Research|November 15, 1988
Combined modality therapy with bleomycin, hyperthermia, and radiationB A Teicher, T S Herman, S A Holden
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Combination of antiangiogenic therapy with other anticancer therapies: results, challenges, and open questionsGiampietro Gasparini, Raffaele Longo, Massimo Fanelli, et al.
Pageof 38